Search
Search Results
-
Budget impact of endovascular treatment for acute ischaemic stroke patients in the Netherlands for 2015–2021
IntroductionEndovascular treatment (EVT) has been proven to be both effective and cost-effective for patients with acute ischaemic stroke. We...
-
A budget impact analysis of a digital monitoring solution in patients treated with oral anticancer agents: a medico-economic analysis of the randomized phase 3 CAPRI trial
Background/ObjectivesRemote patient monitoring (RPM) has demonstrated numerous benefits in cancer care, including improved quality of life, overall...
-
Budget Impact Analysis of Idecabtagene Vicleucel for the Treatment of Adult Patients with Relapsed or Refractory Multiple Myeloma in the US
BackgroundGene therapy is known to be unaffordable to those who need it the most; however, evidence on the financial impact is limited.
...
-
Cost-effectiveness and potential budget impact of non-pharmacological interventions for early management in prehypertensive people: an economic evaluation for China
BackgroundNon-pharmacological interventions (NPIs) could be considered in the early management of prehypertensive population. This study aimed to...
-
Budget impact analysis of the subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in the Big-5 European (E5) countries
BackgroundIn 2020, the European Medicines Agency approved infliximab subcutaneous (SC) for the treatment of inflammatory bowel disease. This new mode...
-
A Budget Impact Model of Maintenance Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with IgPro20 (Hizentra) Relative to Intravenous Immunoglobulin in the United States
BackgroundChronic inflammatory demyelinating polyneuropathy (CIDP) is a rare, progressive autoimmune disease causing peripheral nervous system...
-
Cost-effectiveness and budget impact analysis of lisdexamfetamine versus methylphenidate for patients under 18 with attention-deficit/hyperactivity disorder in Iran
BackgroundLisdexamfetamine (LDX) and Methylphenidate (MPH) are stimulant agents that have been shown to provide significant benefits in the...
-
Budget impact analysis of a Lifestyle-integrated Functional Exercise (LiFE) program for older people in Germany: a Markov model based on data from the LiFE-is-LiFE trial
BackgroundFall prevention is important for healthy ageing, but the economic impact of fall prevention are scarcely investigated. A recent...
-
Budget Impact Analysis of Vibegron for the Treatment of Overactive Bladder in the USA
BackgroundOveractive bladder (OAB) is associated with considerable clinical and economic burden. Treatment of patients with OAB using...
-
Budget Impact of Three Improvement Targets for Compression Therapy for Patients with Deep Venous Thrombosis in The Netherlands
Background and ObjectiveCompression therapy following deep venous thrombosis in the Netherlands is suboptimal. We assessed the budget impact of...
-
Hospitalization budget impact during the COVID-19 pandemic in Spain
ObjectivesThe aim was to determine the direct impact of the COVID-19 pandemic on Spain’s health budget.
MethodsBudget impact analyses based on...
-
Cost-effectiveness and budget impact analysis of enzalutamide in comparison to abiraterone in treatment of metastatic prostate cancer resistant to castration in Iran
IntroductionIn recent years, enzalutamide and abiraterone have been widely used as treatments for metastatic castration-resistant prostate cancer...
-
Budget Impact Analysis of an Epigenetic Test Used for Diagnosing Fetal Alcohol Spectrum Disorder from the Perspective of a Laboratory Budget Holder in Manitoba, Canada
Background and AimsFetal alcohol spectrum disorder (FASD) is a condition that results from prenatal alcohol exposure. Though diagnosis is important...
-
Budget Impact and Cost-Effectiveness of Intravenous Meloxicam to Treat Moderate–Severe Postoperative Pain
IntroductionThis study assesses the budget impact and cost-effectiveness of intravenous meloxicam (MIV) to treat moderate–severe acute postoperative...
-
Exploration of an alternative reconstructed individual patient data-based approach for budget impact analysis of anticancer drugs
BackgroundThe duration of treatment (DOT) of the initial intervention and subsequent treatment is the key to determining the accuracy of...
-
Cost-Effectiveness and Budget Impact of a Novel Antithrombotic Drug Removal System to Reduce Bleeding Risk in Patients on Preoperative Ticagrelor Undergoing Cardiac Surgery
BackgroundAntithrombotic drugs, including the P2Y 12 inhibitor ticagrelor, increase the risk of perioperative bleeding in patients requiring urgent...
-
Budget Impact Analysis of Risperidone Use and Adverse Event Monitoring in Autism Spectrum Disorder in Brazil: Assessment of Theoretical Versus Real Data
Background and aimsRisperidone is used in autism spectrum disorder (ASD) to manage aggressive behavior. Budget impact analysis (BIA) assists managers...
-
Cost-Effectiveness, Burden of Disease and Budget Impact of Inclisiran: Dynamic Cohort Modelling of a Real-World Population with Cardiovascular Disease
ObjectiveWe aimed to estimate the cost-effectiveness, burden of disease and budget impact of inclisiran added to standard-of-care lipid-lowering...
-
Budget Impact Analysis of the FreeStyle Libre Flash Continuous Glucose Monitoring System® in Patients with Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus with Multiple Daily Insulin Injections in Argentina
ObjectiveTo estimate the budget impact of the potential coverage of FreeStyle Libre Flash Continuous Glucose Monitoring System (FSL) for glycemia...
-
Cost-Effectiveness and Budget Impact Analysis of Implementing a 'Soft Opt-Out' System for Kidney Donation in Australia
IntroductionThere is a severe shortage of donor organs globally. There is growing interest in understanding how a 'soft opt-out' organ donation...
